Gene Delivery in Bone Tissue Engineering: Progress and Prospects Using Viral and Nonviral Strategies
- 1 January 2004
- journal article
- review article
- Published by Mary Ann Liebert Inc in Tissue Engineering
- Vol. 10 (1-2) , 295-307
- https://doi.org/10.1089/107632704322791934
Abstract
Bone tissue loss as a consequence of the natural aging process or as a result of trauma and degenerative disease has led to the need for procedures to generate cartilage and bone for a variety of orthopedic applications. The ability to transfer genes into multipotential mesenchymal stem cells, while still in its infancy, offers considerable therapeutic hope in a variety of musculoskeletal disorders. However, the choice of gene delivery method is key. This review examines the various techniques and methods currently available to enable gene transfer into a target population from viral methods (transduction) to nonviral (transfection) methods and the limitations associated with each method. The potential applications and current understanding of each method are presented. Given the demographic challenge of an aging population, the ultimate goal remains the development of simple, safe, and reproducible strategies for gene delivery that will address the pressing orthopedic clinical imperatives of many.Keywords
This publication has 78 references indexed in Scilit:
- Staged reduction and stabilisation in chronic atlantoaxial rotatory fixationThe Journal of Bone and Joint Surgery. British volume, 2002
- Enhancement of Bone Healing Based onEx VivoGene Therapy Using Human Muscle-Derived Cells Expressing Bone Morphogenetic Protein 2Human Gene Therapy, 2002
- Bone Tissue Engineering: Hope vs HypeBiochemical and Biophysical Research Communications, 2002
- Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectorsGene Therapy, 2001
- TrueGene Therapy, 2000
- The Monoclonal Antibody SH-2, Raised against Human Mesenchymal Stem Cells, Recognizes an Epitope on Endoglin (CD105)Biochemical and Biophysical Research Communications, 1999
- In vivo gene delivery by electroporationAdvanced Drug Delivery Reviews, 1999
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998
- Enhanced and Specific Gene Expression via Tissue-Specific Production of Cre Recombinase Using Adenovirus VectorBiochemical and Biophysical Research Communications, 1998
- MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignanciesLeukemia, 1998